NIH-funded research R01 grant

Metabolic signatures that predict outcomes in children with Crohn's

Official title: Population-Based Characterization of Metabolic Pathways to Predict Pediatric Crohn's Disease Outcomes

Funded at Duke University · NIH-11371199 · Data updated 2026-11-12

This project looks at metabolism patterns in children with Crohn's disease to help predict how their condition will progress and respond to treatments.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startApril 25, 2025
Project endApril 30, 2027
Funding year2026
Award (this year)$610,170
NIH project number5R01DK132369-05
Project IDNIH-11371199 on NIH RePORTER

Who could benefit from this research

Could help

Children diagnosed with pediatric Crohn's disease (especially young children and those within typical pediatric age ranges) would be the ideal candidates for contributing data or samples.

Less likely to help

People without Crohn's disease or adults with only adult-onset Crohn's may not directly benefit from this pediatric-focused work, and it is not a treatment that provides immediate clinical benefit to participants.

What this research studies

If your child has Crohn's, researchers will analyze gene activity from blood and tissue samples to find metabolic patterns linked to worse outcomes. They will combine data from many children across populations and use computer models to map changes in lipids, amino acids, and other metabolic pathways. The team will link those metabolic signatures to disease subtypes, structural complications, and treatment responses. The aim is to create markers that could help doctors choose the right level of therapy for each child.

Why it matters

Potential benefit: If successful, this work could help doctors predict which children are at higher risk of progression and tailor treatments to avoid unnecessary side effects.

How similar studies have gone: Previous studies have found metabolic changes in Crohn's and early laboratory work suggests targeting some pathways (for example the mevalonate pathway) may help, but large-scale clinical validation is still limited.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Syed, Sana — Duke University
  • Study coordinator: Syed, Sana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.